BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32464642)

  • 1. Myocardial injury in severe COVID-19 infection.
    Jaffe AS; Cleland JGF; Katus HA
    Eur Heart J; 2020 Jun; 41(22):2080-2082. PubMed ID: 32464642
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality.
    Bonow RO; Fonarow GC; O'Gara PT; Yancy CW
    JAMA Cardiol; 2020 Jul; 5(7):751-753. PubMed ID: 32219362
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?
    Giannopoulos G; Vrachatis DA; Deftereos SG
    JAMA Cardiol; 2020 Sep; 5(9):1069-1070. PubMed ID: 32936267
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].
    Ding YQ; Bian XW
    Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):291-293. PubMed ID: 32268662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Injury in COVID-19 Patients: The Beginning or the End?
    Uriel N; Sayer G; Clerkin KJ
    J Am Coll Cardiol; 2020 Aug; 76(5):547-549. PubMed ID: 32731932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination Methods of 2019 Novel Coronavirus (SARS-CoV-2)].
    Pan X; Yao Y; Cao C; Huang Y; Wu J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Apr; 44(4):359-362. PubMed ID: 32762214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Errors in Tracing Coronavirus SARS-CoV-2 Transmission Using a Maximum Likelihood Tree. Comment on "A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis".
    Forster P; Forster L
    JMIR Public Health Surveill; 2020 Nov; 6(4):e23542. PubMed ID: 33174859
    [No Abstract]   [Full Text] [Related]  

  • 8. Atypical Imaging Findings in Leukemia With SARS-CoV-2 Infection.
    Zhou S; Wu G
    AJR Am J Roentgenol; 2020 Aug; 215(2):W31-W32. PubMed ID: 32352310
    [No Abstract]   [Full Text] [Related]  

  • 9. Rhabdomyolysis as Potential Late Complication Associated with COVID-19.
    Chan KH; Slim J
    Emerg Infect Dis; 2020 Oct; 26(10):2535. PubMed ID: 32614765
    [No Abstract]   [Full Text] [Related]  

  • 10. Implications for the Care of Patients With COVID-19 and Inflammatory Myocardial Disease.
    Di Tano G; Iacovoni A; De Maria R
    JAMA Cardiol; 2020 Nov; 5(11):1305-1306. PubMed ID: 32822458
    [No Abstract]   [Full Text] [Related]  

  • 11. Melatonin as a putative protection against myocardial injury in COVID-19 infection.
    Simko F; Hrenak J; Dominguez-Rodriguez A; Reiter RJ
    Expert Rev Clin Pharmacol; 2020 Sep; 13(9):921-924. PubMed ID: 32893686
    [No Abstract]   [Full Text] [Related]  

  • 12. Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?-Reply.
    Fan Y; Guo T; Lu Z
    JAMA Cardiol; 2020 Sep; 5(9):1070-1071. PubMed ID: 32936268
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatments for COVID-19: emerging drugs against the coronavirus.
    Khademolhosseini S; Kavandi H; Ghaffari S
    Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of COVID-19 on Italy: A Lesson for the Future.
    Santacroce L; Bottalico L; Charitos IA
    Int J Occup Environ Med; 2020 Jul; 11(3):151-152. PubMed ID: 32225178
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatments for COVID-19: emerging drugs against the coronavirus - reply.
    Potì F
    Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921741
    [No Abstract]   [Full Text] [Related]  

  • 16. Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)-An Old Drug With New Life?
    Rabbani AB; Parikh RV; Rafique AM
    JAMA Netw Open; 2020 Jun; 3(6):e2013556. PubMed ID: 32579190
    [No Abstract]   [Full Text] [Related]  

  • 17. [DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)].
    Otto-Knapp R; Häcker B; Breuer C; Diel R; Kaufmann SHE; Korr G; Pfeiffer M; Schaberg T; Schönfeld N; Witte P; Bauer T
    Pneumologie; 2020 Jul; 74(7):412-416. PubMed ID: 32674189
    [No Abstract]   [Full Text] [Related]  

  • 18. The duration of SARS-CoV-2 shedding in patients recovering from COVID-19.
    Cimrman Š; Macková L; Král V; Bartoš H; Stiborová I; Dlouhý P
    Epidemiol Mikrobiol Imunol; 2020; 69(3):148-151. PubMed ID: 33086857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hundred days into the coronavirus disease (COVID-19) pandemic.
    Steffens I
    Euro Surveill; 2020 Apr; 25(14):. PubMed ID: 32290905
    [No Abstract]   [Full Text] [Related]  

  • 20. The dilemmas of the classification of SARS-CoV-2 infection without clinical manifestations: Asymptomatic or presymptomatic.
    Arteaga-Livias K; Pecho-Silva S; Panduro-Correa V; Rodríguez-Morales AJ
    J Formos Med Assoc; 2020 Jul; 119(7):1237-1238. PubMed ID: 32405157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.